NexImmune, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 9.57 million compared to USD 15.02 million a year ago. Basic loss per share from continuing operations was USD 9.25 compared to USD 16.5 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.6 USD | +4.05% | +8.43% | +62.16% |
04-17 | North American Morning Briefing : Stock Futures -2- | DJ |
04-16 | NexImmune, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+62.16% | 4.94M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- NEXI Stock
- News NexImmune, Inc.
- NexImmune, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023